{
  "paper_metadata": {
    "pmid": "37306523",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for the BRCA2 gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3170_3174del",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 19,
        "demographics": "Not specified",
        "phenotype": "Breast cancer, rectal cancer, colon cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 5,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 71.43,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Carriers were significantly more likely to have breast cancer than non-carriers (p = 8e\u221206), with 50% of carriers having breast cancer across four unrelated families."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "rectal cancer",
          "evidence_sentence": "Four patients carrying BRCA2 variants had rectal cancer."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "colon cancer",
          "evidence_sentence": "Three had colon cancer."
        }
      ],
      "functional_data": {
        "summary": "All PVs observed within BRCA2 were deletion or duplication events which significantly disrupt gene function.",
        "assays": []
      },
      "segregation_data": "Yes, appeared only in cancer patients and high-risk patients.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The most frequent BRCA2 variant in this sample was the previously considered VUS c.122C>T, although carriers with cancer did not report breast cancer.",
      "key_quotes": [
        "All PVs observed within BRCA2 were deletion or duplication events which significantly disrupt gene function.",
        "Carriers were significantly more likely to have breast cancer than non-carriers (p = 8e\u221206), with 50% of carriers having breast cancer across four unrelated families."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4787del",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 19,
        "demographics": "Not specified",
        "phenotype": "Breast cancer, rectal cancer, colon cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 5,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 71.43,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Carriers were significantly more likely to have breast cancer than non-carriers (p = 8e\u221206), with 50% of carriers having breast cancer across four unrelated families."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "rectal cancer",
          "evidence_sentence": "Four patients carrying BRCA2 variants had rectal cancer."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "colon cancer",
          "evidence_sentence": "Three had colon cancer."
        }
      ],
      "functional_data": {
        "summary": "All PVs observed within BRCA2 were deletion or duplication events which significantly disrupt gene function.",
        "assays": []
      },
      "segregation_data": "Yes, appeared only in cancer patients and high-risk patients.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The most frequent BRCA2 variant in this sample was the previously considered VUS c.122C>T, although carriers with cancer did not report breast cancer.",
      "key_quotes": [
        "All PVs observed within BRCA2 were deletion or duplication events which significantly disrupt gene function.",
        "Carriers were significantly more likely to have breast cancer than non-carriers (p = 8e\u221206), with 50% of carriers having breast cancer across four unrelated families."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5557dup",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 19,
        "demographics": "Not specified",
        "phenotype": "Breast cancer, rectal cancer, colon cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 7,
        "affected_count": 5,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 71.43,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "Carriers were significantly more likely to have breast cancer than non-carriers (p = 8e\u221206), with 50% of carriers having breast cancer across four unrelated families."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "rectal cancer",
          "evidence_sentence": "Four patients carrying BRCA2 variants had rectal cancer."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "colon cancer",
          "evidence_sentence": "Three had colon cancer."
        }
      ],
      "functional_data": {
        "summary": "All PVs observed within BRCA2 were deletion or duplication events which significantly disrupt gene function.",
        "assays": []
      },
      "segregation_data": "Yes, appeared only in cancer patients and high-risk patients.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The most frequent BRCA2 variant in this sample was the previously considered VUS c.122C>T, although carriers with cancer did not report breast cancer.",
      "key_quotes": [
        "All PVs observed within BRCA2 were deletion or duplication events which significantly disrupt gene function.",
        "Carriers were significantly more likely to have breast cancer than non-carriers (p = 8e\u221206), with 50% of carriers having breast cancer across four unrelated families."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Supplementary Table 3",
      "table_caption": "List of variants discovered in each patient group",
      "variants_extracted": 3
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were extracted successfully."
  }
}